Terms: = Kidney tumors AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
35 results:
1. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
2. An enhanced recovery after surgery protocol in children who undergo nephrectomy for Wilms tumor safely shortens hospital stay.
Moon JK; Hwang R; Balis FM; Mattei P
J Pediatr Surg; 2022 Oct; 57(10):259-265. PubMed ID: 35768311
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and management of pleural effusions in patients with Wilms tumor: A Pediatric Surgical Oncology Research Collaborative study.
Al-Hadidi A; Rinehardt HN; Sutthatarn P; Talbot LJ; Murphy AJ; Whitlock R; Condon S; Naik-Mathuria B; Utria AF; Rothstein DH; Chen SY; Wong-Michalak S; Kim ES; Short SS; Meyers RL; Kastenberg ZJ; Johnston ME; Zens T; Dasgupta R; Malek MM; Calabro K; Piché N; Callas H; Lautz TB; McKay K; Lovvorn HN; Commander SJ; Tracy ET; Lund SB; Polites SF; Davidson J; Dhooma J; Seemann NM; Marquart JP; Gainer H; Lal DR; Rich BS; Glick RD; Maloney L; Radu S; Fialkowski EA; Kwok PE; Romao RLP; Rubalcava N; Ehrlich PF; Newman E; Diehl T; Le HD; Polcz V; Petroze RT; Stanek J; Aldrink JH
Int J Cancer; 2022 Nov; 151(10):1696-1702. PubMed ID: 35748343
[TBL] [Abstract] [Full Text] [Related]
4. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
Paez R; Shah C; Cords AJ; Muterspaugh A; Helton JE; Antic S; Eisenberg R; Chen H; Grogan EL; Manning HC; Walker RC; Massion PP
PLoS One; 2022; 17(3):e0265427. PubMed ID: 35294486
[TBL] [Abstract] [Full Text] [Related]
5. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
Karam JA; Puligandla M; Flaherty KT; Uzzo RG; Matin SF; Pins MR; Wood CG; Kane C; Jewett MAS; Kim SE; Dutcher JP; DiPaola RS; Haas NB
BJU Int; 2022 Jun; 129(6):718-722. PubMed ID: 34480522
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
[TBL] [Abstract] [Full Text] [Related]
8. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract] [Full Text] [Related]
9. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC
Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446
[TBL] [Abstract] [Full Text] [Related]
10. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
[TBL] [Abstract] [Full Text] [Related]
11. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
Seibel NL; Chi YY; Perlman EJ; Tian J; Sun J; Anderson JR; Ritchey ML; Thomas PR; Miser J; Kalapurakal JA; Grundy PE; Green DM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27450. PubMed ID: 30255545
[TBL] [Abstract] [Full Text] [Related]
12. A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer.
Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H
Mol Imaging Biol; 2017 Dec; 19(6):915-922. PubMed ID: 28924629
[TBL] [Abstract] [Full Text] [Related]
13. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.
Sandberg JK; Mullen EA; Cajaiba MM; Smith EA; Servaes S; Perlman EJ; Geller JI; Ehrlich PF; Cost NG; Dome JS; Fernandez CV; Khanna G
Pediatr Radiol; 2017 Nov; 47(12):1615-1621. PubMed ID: 28689245
[TBL] [Abstract] [Full Text] [Related]
14. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
[TBL] [Abstract] [Full Text] [Related]
15. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer.
Christakis I; Bussaidy N; Clarke C; Kwatampora LJ; Warneke CL; Silva AM; Williams MD; Grubbs EG; Lee JE; Perrier ND
Ann Surg Oncol; 2016 Sep; 23(9):2889-97. PubMed ID: 27160525
[TBL] [Abstract] [Full Text] [Related]
16. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.
Geller JI; Ehrlich PF; Cost NG; Khanna G; Mullen EA; Gratias EJ; Naranjo A; Dome JS; Perlman EJ
Cancer; 2015 Jul; 121(14):2457-64. PubMed ID: 25845370
[TBL] [Abstract] [Full Text] [Related]
18. Readability of American online patient education materials in urologic oncology: a need for simple communication.
Pruthi A; Nielsen ME; Raynor MC; Woods ME; Wallen EM; Smith AB
Urology; 2015 Feb; 85(2):351-6. PubMed ID: 25623686
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group.
Servaes S; Khanna G; Naranjo A; Geller JI; Ehrlich PF; Gow KW; Perlman EJ; Dome JS; Gratias E; Mullen EA
Pediatr Radiol; 2015 Feb; 45(2):166-72. PubMed ID: 25135711
[TBL] [Abstract] [Full Text] [Related]
20. Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.
Wang HH; Abern MR; Cost NG; Chu DI; Ross SS; Wiener JS; Routh JC
J Urol; 2014 Oct; 192(4):1196-202. PubMed ID: 24735935
[TBL] [Abstract] [Full Text] [Related]
[Next]
